E
E for L Aim PCL
SET:EFORL
E for L Aim PCL
SET:EFORL
Price:
0.14
THB
Market Closed
Market Cap:
฿559.8m
Relative Value
The Relative Value of one EFORL stock under the Base Case scenario is 0.38 THB. Compared to the current market price of 0.14 THB, E for L Aim PCL is Undervalued by 63%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
EFORL
Relative Value
Base Case
0.38
THB
Undervaluation 63%
E
Multiples Across Competitors
EFORL Competitors Multiples
E for L Aim PCL Competitors
E for L Aim PCL Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TH |
E
|
E for L Aim PCL
SET:EFORL
|
559.8m THB | 0.4 | 9.7 | 5.6 | 8.9 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
109B USD | 0.3 | 25.1 | 17.6 | 19.8 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
64.5B USD | 0.2 | 39.7 | 14 | 17.7 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.6B USD | 0.2 | 39.2 | 13.8 | 17.5 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
49B USD | 0.2 | 29.5 | 14.3 | 18.6 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
32B AUD | 2.8 | 35.1 | 26.1 | 26.1 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
63.4B CNY | 0.2 | 11.2 | 15.2 | 15.2 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
62.5B CNY | 1.5 | 16.9 | 13.1 | 13.1 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.4B USD | 0.6 | 21 | 10.3 | 14.5 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
64.9B HKD | 0.1 | 8.4 | 1.5 | 1.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
